| 1 |
From Energy Metabolic Change to Precision Therapy: a Holistic View of Energy Metabolism in Heart Failure |
|
| | Jianpei Wen, Chen Chen | | | Journal of Cardiovascular Translational Research. 2023; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Use of Ranolazine for the Treatment of Coronary Microvascular Dysfunction |
|
| | Randall P. Sharp,Edna Patatanian,Riaz Sirajuddin | | | American Journal of Cardiovascular Drugs. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
“Pill in the Pocket” Antiarrhythmic Drugs for Orally Administered Pharmacologic Cardioversion of Atrial Fibrillation |
|
| | James A. Reiffel,Alessandro Capucci | | | The American Journal of Cardiology. 2021; 140: 55 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Phospho-ablation of cardiac sodium channel Nav1.5 mitigates susceptibility to atrial fibrillation and improves glucose homeostasis under conditions of diet-induced obesity |
|
| | Revati S. Dewal,Amara Greer-Short,Cemantha Lane,Shinsuke Nirengi,Pedro Acosta Manzano,Diego Hernández-Saavedra,Katherine R. Wright,Drew Nassal,Lisa A. Baer,Peter J. Mohler,Thomas J. Hund,Kristin I. Stanford | | | International Journal of Obesity. 2021; 45(4): 795 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Diabetogenic effects of cardioprotective drugs |
|
| | David S.H. Bell,Edison Goncalves | | | Diabetes, Obesity and Metabolism. 2021; 23(4): 877 | | | [Pubmed] [Google Scholar] [DOI] | |
|
